是高效选择性EGFR突变体抑制剂,对外显子19缺失型EGFR、L858R/T790M EGFR和野生型EGFR的IC50分别为12.92 nM,11.44 nM和493.8。
L858R/T790M EGFR,Exon 19 deletion EGFR ,WT EGFR ;
Orally bioavailable mutant-selective EGFR inhibitor that has been tested in Phase III clinical trials for treatment of Non-Small Cell Lung Cancer